Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ARID1A Mutations Promote P300-Dependent Endometrial Invasion through Super-Enhancer Hyperacetylation
Mike R. Wilson, Jake J. Reske, Jeanne Holladay, et al.
Cell Reports (2020) Vol. 33, Iss. 6, pp. 108366-108366
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6
Saisai Chen, Kai Lǚ, Yue Hou, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 4, pp. e006020-e006020
Open Access | Times Cited: 52
Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis
Wei Zhou, Heng Liu, Zhe Yuan, et al.
Cancer Cell (2023) Vol. 41, Iss. 4, pp. 740-756.e10
Open Access | Times Cited: 44
Epigenetic Dysregulation in Endometriosis: Implications for Pathophysiology and Therapeutics
Ryan M. Marquardt, Dinh Nam Tran, Bruce A. Lessey, et al.
Endocrine Reviews (2023) Vol. 44, Iss. 6, pp. 1074-1095
Open Access | Times Cited: 29
Pan-Cancer Comparative and Integrative Analyses of Driver Alterations Using Japanese and International Genomic Databases
Sara Horie, Yuki Saito, Yasunori Kogure, et al.
Cancer Discovery (2024) Vol. 14, Iss. 5, pp. 786-803
Closed Access | Times Cited: 15
Omics-based novel strategies in the diagnosis of endometriosis
Mohammad Samare‐Najaf, Seyed Ali Razavinasab, Ali Samareh, et al.
Critical Reviews in Clinical Laboratory Sciences (2023) Vol. 61, Iss. 3, pp. 205-225
Closed Access | Times Cited: 19
ARID1A loss derepresses a group of human endogenous retrovirus-H loci to modulate BRD4-dependent transcription
Chunhong Yu, Xiaoyun Lei, Fang Chen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 25
Enhancer RNAs: mechanisms in transcriptional regulation and functions in diseases
Qianhui Li, Xin Liu, Jingtao Wen, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Treatment Strategies for ARID1A-Deficient Ovarian Clear Cell Carcinoma
Kazuaki Takahashi, Masataka Takenaka, Aikou Okamoto, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1769-1769
Open Access | Times Cited: 31
Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis
Jake J. Reske, Mike R. Wilson, Jeanne Holladay, et al.
PLoS Genetics (2021) Vol. 17, Iss. 12, pp. e1009986-e1009986
Open Access | Times Cited: 28
Microglia homeostasis mediated by epigenetic ARID1A regulates neural progenitor cells response and leads to autism-like behaviors
Libo Su, Mengtian Zhang, Fen Ji, et al.
Molecular Psychiatry (2022) Vol. 29, Iss. 6, pp. 1595-1609
Closed Access | Times Cited: 22
Emerging Themes in Mechanisms of Tumorigenesis by SWI/SNF Subunit Mutation
Cheyenne A. Jones, William P. Tansey, April M. Weissmiller
Epigenetics Insights (2022) Vol. 15
Open Access | Times Cited: 22
ARID1A-dependent maintenance of H3.3 is required for repressive CHD4-ZMYND8 chromatin interactions at super-enhancers
Jake J. Reske, Mike R. Wilson, Brooke Armistead, et al.
BMC Biology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 19
FOXM1, a super enhancer-associated gene, is related to poorer prognosis and gemcitabine resistance in pancreatic cancer
Jian Jiang, Tong Shen, Dan Chen, et al.
Cell Biochemistry and Biophysics (2025)
Closed Access
Mettl3/Eed/Ythdc1 regulatory axis controls endometrial receptivity and function
Xiujuan Hu, Jincheng Li, Chenyue Ding, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Transcription factor addictions: exploring the potential Achilles’ Heel of endometriosis
Yang Yang, Yi Du, Xiaoling Ma, et al.
Science China Life Sciences (2025)
Closed Access
Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma—rationale for targeting ARID1A deficiency
Xiaochuan Dong, Shumei Song, Yuan Li, et al.
Gut (2021) Vol. 71, Iss. 3, pp. 467-478
Open Access | Times Cited: 26
SWI/SNF Antagonism of PRC2 Mediates Estrogen-Induced Progesterone Receptor Expression
Mike R. Wilson, Jake J. Reske, Julie Koeman, et al.
Cells (2022) Vol. 11, Iss. 6, pp. 1000-1000
Open Access | Times Cited: 17
Acetate supplementation restores cognitive deficits caused by ARID1A haploinsufficiency in excitatory neurons
Pei‐Pei Liu, Shang‐Kun Dai, Ting‐Wei Mi, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 12
Open Access | Times Cited: 14
Etiology of super-enhancer reprogramming and activation in cancer
Royce Zhou, Ramon Parsons
Epigenetics & Chromatin (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on Cancer Therapies including Immunotherapy
Yijiang Shi, Daniel Sanghoon Shin
Biomolecules (2023) Vol. 13, Iss. 6, pp. 984-984
Open Access | Times Cited: 7
Super-enhancers: drivers of cells’ identities and cells’ debacles
Mélanie Lavaud, Robel Tesfaye, Léa Lassous, et al.
Epigenomics (2024) Vol. 16, Iss. 9, pp. 681-700
Closed Access | Times Cited: 2
Development and validation of a novel anoikis-related gene signature for predicting prognosis in ovarian cancer
Shuangfeng Qian, Yidan Wen, Lina Mei, et al.
Aging (2023) Vol. 15, Iss. 9, pp. 3410-3426
Open Access | Times Cited: 5
AP-1 Subunit JUNB Promotes Invasive Phenotypes in Endometriosis
Mike R. Wilson, Jake J. Reske, Ronald L. Chandler
Reproductive Sciences (2022) Vol. 29, Iss. 11, pp. 3266-3277
Open Access | Times Cited: 8
NFATc1 Is a Central Mediator of EGFR-Induced ARID1A Chromatin Dissociation During Acinar Cell Reprogramming
Zhe Zhang, Xin Wang, Feda H. Hamdan, et al.
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 5, pp. 1219-1246
Open Access | Times Cited: 4
Identification of somatic mutation-driven enhancers and their clinical utility in breast cancer
Hongying Zhao, Ke Feng, Junjie Lei, et al.
iScience (2024) Vol. 27, Iss. 2, pp. 108780-108780
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top